Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese

被引:42
|
作者
Gao, Y [1 ]
Zhang, Q [1 ]
机构
[1] Sun Yat Sen Univ Med Sci, Sch Publ Hlth, Res Unit Mol Toxicol, Guangzhou 510089, Peoples R China
关键词
lung neoplasm; GSTM1; CYP2D6; genetic polymorphism; case-control study;
D O I
10.1016/S1383-5718(99)00092-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The case-control study was conducted to examine the association between GSTM1 null and CYP2D6Ch (T-188/T) genotypes and lung cancer risk among Chinese of Han nationality Living in Guangdong. All 191 subjects were investigated with unitary questionnaire and their DNAs were isolated from peripheral lymphocytes by standard procedures with proteinase K digestion and phenol/chloroform extraction. GSTM1(-) was detected with polymerase chain reaction (PCR) in all 191 subjects, involving 59 lung cancer cases, 59 hospital controls and 73 healthy controls. The frequencies of GSTM1(-) were not significantly different between the cases and the two controls overall. However, among adenocarcinoma of lung, the frequency of GSTM1(-) (76.9%) appeared to be higher than that in controls (49.2%), and the odd radios were 3.42-3.45. The results suggested an elevated risk for adenocarcinoma of lung would be shown by GSTM1(-). Using polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) to detect CYP2D6 T-188/T genotype in 59 lung cancer patients and 59 hospital controls, it showed no significant difference between the two groups. However, non-smokers with non-T-188/T (C-188/C or C-188/T) genotype showed 3.78-folds increased risk of lung cancer compared with those with T-188/T genotype (P = 0.036). The data did not suggest a substantial interaction effect between GSTM1 and CYP2D6 polymorphisms and the risk of lung cancer. Additionally, among Chinese (Han) of Guangdong, the frequency of CYP2D6 T-188 allele appeared to be 57.2%, and GSTM1(-) to be 51.8%. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:441 / 449
页数:9
相关论文
共 50 条
  • [31] Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk
    Dialyna, IA
    Miyakis, S
    Georgatou, N
    Spandidos, DA
    ONCOLOGY REPORTS, 2003, 10 (06) : 1829 - 1835
  • [32] Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems
    Landtblom, AM
    Wastenson, M
    Ahmadi, A
    Söderkvist, P
    NEUROLOGICAL SCIENCES, 2003, 24 (04) : 248 - 251
  • [33] Polymorphisms in detoxilication genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility
    González, A
    Ramírez, V
    Cuenca, P
    Sierra, R
    REVISTA DE BIOLOGIA TROPICAL, 2004, 52 (03) : 591 - 600
  • [34] CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations:: A meta-analysis
    Shi, Xiuquan
    Zhou, Suhua
    Wang, Zhongxu
    Zhou, Zongcan
    Wang, Zengzhen
    LUNG CANCER, 2008, 59 (02) : 155 - 163
  • [35] Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children
    Joseph, T
    Kusumakumary, P
    Chacko, P
    Abraham, A
    Pillai, MR
    PEDIATRIC BLOOD & CANCER, 2004, 43 (05) : 560 - 567
  • [36] CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia
    Idris, Hadeil M. E.
    Khalil, Hiba B.
    Mills, Jeremy
    Elderdery, Abozer Y.
    CURRENT CANCER DRUG TARGETS, 2020, 20 (09) : 675 - 680
  • [37] Analysis of CYP2D6 expression in human lung: Implications for the association between CYP2D6 activity and susceptibility to lung cancer
    Kivisto, KT
    Griese, KU
    Stuven, T
    Fritz, P
    Friedel, G
    Kroemer, HK
    Zanger, UM
    PHARMACOGENETICS, 1997, 7 (04): : 295 - 302
  • [38] Associations of CYP1A1, GSTM1 and GSTT1 Polymorphisms with Lung Cancer Susceptibility in a Northern Indian Population
    Shukla, R. K.
    Tilak, A. R.
    Kumar, C.
    Kant, S.
    Kumar, A.
    Mittal, B.
    Bhattacharya, S.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 3345 - 3349
  • [39] Genetic polymorphisms of CYP2D6 in Chinese mainland
    Ji, L
    Pan, SX
    Wu, JM
    Marti-Jaun, J
    Hersberger, M
    CHINESE MEDICAL JOURNAL, 2002, 115 (12) : 1780 - 1784
  • [40] CYP2D6 GENOTYPING AND THE ASSOCIATION WITH LUNG-CANCER SUSCEPTIBILITY
    WOLF, CR
    SMITH, CAD
    BISHOP, T
    FORMAN, D
    GOUGH, AC
    SPURR, NK
    PHARMACOGENETICS, 1994, 4 (02): : 104 - 106